Cinnamaldehyde and its derivatives, a novel class of antifungal agents

Fitoterapia

Volumn 112, Issue , 2016, Pages 116-131

  Shreaz, Sheikh ^a   Wani, Waseem A ^b   Behbehani, Jawad M ^a   Raja, Vaseem ^c   Irshad, Md ^a   Karched, Maribasappa ^a   Ali, Intzar ^d   Siddiqi, Weqar A ^c   Hun, Lee Ting ^b  

^a KUWAIT UNIVERSITY   (Kuwait)

^b UNIVERSITI TEKNOLOGI MALAYSIA   (Malaysia)

^c JAMIA MILLIA ISLAMIA CENTRAL UNIVERSITY   (India)

^d JAWAHARLAL NEHRU UNIVERSITY   (India)

Author keywords

Cinnamaldehyde; Cinnamaldehyde derivatives; Fungal infections; Mechanism of action and future perspectives; Synergistic effects

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ANTIFUNGAL AGENT; CINNAMALDEHYDE; CINNAMALDEHYDE DERIVATIVE; FLUCONAZOLE; ACROLEIN;

ANTIFUNGAL ACTIVITY; ANTIFUNGAL RESISTANCE; BIOSYNTHESIS; CINNAMON; DEVELOPMENT; DNA BINDING; DRUG MECHANISM; DRUG SAFETY; FUNGAL CELL WALL; HUMAN; LIVER TOXICITY; MINIMUM FUNGICIDAL CONCENTRATION; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; STRUCTURE ACTIVITY RELATION; THERAPY EFFECT; ANALOGS AND DERIVATIVES; ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECTS; DRUG POTENTIATION; FUNGUS; YEAST;

ACROLEIN; ANIMALS; ANTIFUNGAL AGENTS; DRUG SYNERGISM; FUNGI; HUMANS; MOLECULAR STRUCTURE; YEASTS;

EID: 84974555878     PISSN: 0367326X     EISSN: 18736971     Source Type: Journal    
DOI: 10.1016/j.fitote.2016.05.016     Document Type: Review

References (273)

1. B. Havlickova, V.A. Czaika, and M. Friedrich Epidemiological trends in skin mycoses worldwide Mycoses 51 2008 2 15
2. B. Wanke, M.S. Lazera, and M. Nucci Fungal infections in the immunocompromised host Mem. Inst. Oswaldo Cruz 95 2000 153 158
3. H.M. Blumberg, W.R. Jarvis, J.M. Soucie, J.E. Edwards, J.E. Patterson, M.A. Pfaller, M.S. Rangel-Frausto, M.G. Rinaldi, L. Saiman, R.T. Wiblin, R.P. Wenzel, and the NEMIS Study Group Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study Clin. Infect. Dis. 33 2001 177 186
4. S.K. Fridkin The changing face of fungal infections in health care settings Clin. Infect. Dis. 41 2005 1455 1460
5. K. Anaul, and Z. Ahmad Candida infections and their prevention ISRN Pre. Med. 1-13 2013
6. G.S. Martin, D.M. Mannino, S. Eaton, and M. Moss The epidemiology of sepsis in the United States from 1979 through 2000 N. Engl. J. Med. 348 2003 1546 1554
7. M.D. Zilberberg, A.F. Shorr, and M.H. Kollef Secular trends in candidemia-related hospitalization in the United States, 2000-2005 Infect. Control Hosp. Epidemiol. 29 2008 978 980
8. H. Wisplinghoff, T. Bischoff, S.M. Tallent, H. Seifert, R.P. Wenzel, and M.B. Edmond Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study Clin. Infect. Dis. 39 2004 309 317
9. M.A. Kabir, M.A. Hussain, and Z. Ahmad Candida albicans: a model organism for studying fungal pathogens ISRN Microbiol. 1-15 2012
10. M.A. Pfaller The epidemiology of invasive mycoses-narrowing the gap Clin. Infect. Dis. 27 1998 1148 1150
11. M.A. Pfaller, and D.J. Diekema Epidemiology of invasive candidiasis: a persistent public health problem Clin. Microbiol. Rev. 20 2007 133 163
12. K.A. Marr, R.A. Carter, F. Crippa, A. Wald, and L. Corey Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients Clin. Infect. Dis. 34 2002 909 917
13. S. Husain, B.D. Alexander, P. Munoz, and et al. Opportunistic mycelial fungal infections in organ transplant recipients: emerging importance of non-Aspergillus mycelial fungi Clin. Infect. Dis. 37 2003 221 229
14. J.F. Ernst, and A. Schmidt Dimorphism in Human Pathogenic and Apathogenic Yeasts, Basel, Karger, Switzerland 2000
15. P.L. Marichal, S. Koymans, D. Willemsens, P. Bellens, W. Verhasselt, M. Luyten, F.C. Borgers, S. Ramaekers, F.C. Odds, and B.H. Vanden Contributions of mutations in the cytochrome P450 14alpha-demethylase (ERG11, CYP51) to azole resistance in Candida albicans Microbiology 145 1999 2701 2713
16. M.A. Pfaller, P.G. Pappas, and J.R. Wingard Invasive fungal pathogens: current epidemiological trends Clin. Infect. Dis. 43 2006 3 14
17. D.A. Enoch, H.A. Ludlam, and N.M. Brown Invasive fungal infections: a review of epidemiology and management options J. Med. Microbiol. 55 2006 809 818
18. J. Maertens, M. Vrebos, and M. Boogaerts Assessing risk factors for systemic fungal infections Eur. J. Cancer Care 10 2001 56 62
19. R. Tufano Focus on risk factors for fungal infections in ICU patients Minerva Anestesiol. 68 2002 269 272
20. S.K. Fridkin, and W.R. Jarvis Epidemiology of nosocomial fungal infections Clin. Microbiol. Rev. 9 1996 (499-11)
21. P. Eggimann, J. Garbino, and D. Pittet Epidemiology of Candida species infections in critically ill non-immunosuppressed patients Lancet Infect. Dis. 3 2003 (685-02)
22. B.H. Segal, N.G. Almyroudis, M. Battiwalla, R. Herbrecht, J.R. Perfect, T.J. Walsh, and J.R. Wingard Prevention and early treatment of invasive fungal infection in patients with cancer and neutropenia and in stem cell transplant recipients in the era of newer broad-spectrum antifungal agents and diagnostic adjuncts Clin. Infect. Dis. 44 2007 402 409
23. M. Karthaus, and O.A. Cornely Treatment options in candidaemia Mycoses 50 2007 44 49
24. C.K. Murray, F.L. Loo, D.R. Hospenthal, L.C. Cancio, J.A. Jones, S.H. Kim, J.B. Holcomb, C.E. Wade, and S.E. Wolf Incidence of systemic fungal infection and related mortality following severe burns Burns 34 2008 1108 1112
25. K.A. Marr Fungal infections in hematopoietic stem cell transplant recipients Med. Mycol. 46 2008 (293-02)
26. P.G. Pappas, B.D. Alexander, D.R. Andes, S. Hadley, and et al. Invasive fungal infections among organ transplant recipients: results of the transplant-associated infection surveillance network (TRANSNET) Clin. Infect. Dis. 50 2010 1101 1111
27. T.J. Walsh, J. Ito, D.R. Andes, and et al. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the transplant-associated infection surveillance network (TRANSNET) database Clin. Infect. Dis. 50 2010 1091 1100
28. N. Singh, J.M. Aguado, H. Bonatti, and et al. Zygomycosis in solid organ transplant recipients: a prospective, matched casecontrol study to assess risks for disease and outcome J. Infect. Dis. 200 2009 1002 1011
29. J. Ambrosioni, K. Bouchuiguir-Wafa, and J. Garbino Emerging invasive zygomycosis in a tertiary care center: epidemiology and associated risk factors Int. J. Infect. Dis. 14 2010 100 103
30. C. Perego, A. Safdar, H. Kantarjian, R. Champlin, and T.J. Walsh Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases J. Infect. Dis. 191 2005 1350 1360
31. A.H. Groll, S.C. Piscitelli, and T.J. Walsh Clinical pharmacology of systemic antifungal agents: a comprehensive review of agents in clinical use, current investigational compounds, and putative targets for antifungal drug development Adv. Pharmacol. 44 1998 343 500
32. B.S. Charak, R. Louie, B. Malloy, P. Twomey, and A. Mazumder The effect of amphotericin B, aztreonam, imipenem and cephalosporins on the bone marrow progenitor cell activity J. Antimicrob. Chemother. 27 1991 (95-04)
33. T.C. Meeker, M.S. Siegel, F.M. Shiota, J.J. Crowley, and R.W. McGuffin Toxicity of amphotericin B, miconazole and ketoconazole to human granulocyte progenitor cells in vitro Antimicrob. Agents Chemother. 23 1983 169 171
34. D. Abi-Said, E. Anaissie, O. Uzun, I. Raad, H. Pinzcowski, and S. Vartivarian The epidemiology of hematogenous candidiasis caused by different Candida species Clin. Infect. Dis. 24 1997 1122 1128
35. M.F. Price, M.T. LaRocco, and L.O. Gentry Fluconazole susceptibilities of Candida species and distribution of species recovered from blood cultures over a 5-year period Antimicrob. Agents Chemother. 38 1994 1422 1424
36. M.J. Hooth, R.C. Sills, L.T. Burka, J.K. Haseman, K.L. Witt, D.P. Orezech, S. Graves, and J.R. Bucher Toxicology and carcinogenesis studies of microencapsulated trans-cinnamaldehyde in rats and mice Food Chem. Toxicol. 42 2004 1757 1768
37. M. Uchida, S. Nakajin, S. Toyoshima, and M. Shinoda Antioxidative effect of sesamol and related compounds on lipid peroxidation Biol. Pharm. Bull. 19 1996 623 626
38. M.D.A. Krishna, and A.B. Banerjee Antimicrobial screening of some Indian spices Phytother. Res. 13 1999 616 618
39. P.V. Nielsen, and R. Rios Inhibition of fungal growth on bread by volatile components from spices and herbs, and the possible application in active packaging, with special emphasis on mustard essential oil Int. J. Food Microbiol. 60 2000 219 229
40. C.D.W. Cai Land Compounds from Syzgiiun aromaticum possessing growth inhibitory activity against oral pathogens J. Nat. Prod. 59 1996 987 990
41. H.S. Lee, and Y.J. Ahn Growth-inhibiting effects of Cinnamomum cassia bark-derived materials on human intestinal bacteria J. Agric. Food Chem. 46 1998 8 12
42. M. Friedman, P.R. Henika, and R.E. Mandrell Bactericidal activities of plant essential oils and some of their isolated constituents against Campylobacter jejuni, Escherichia coli, Listeria monocytogenes, and Salmonella enterica J. Food Prot. 65 2002 1545 1560
43. S.T. Chang, P.F. Chen, and S.C. Chang Antibacterial activity of leaf essential oils and their constituents from Cinnamomum osmophloeum J. Ethnopharmacol. 77 2001 123 127
44. S. Shreaz, R.A. Sheikh, R. Bhatia, A.A. Hashmi, N. Manzoor, and L.A. Khan Anticandidal activity of cinnamaldehyde, its ligand and Ni (II) complex: effect of increase in ring and side chain Microb. Pathog. 49 2010 75 82
45. Y. Taguchi, T. Takizawa, H. Ishibashi, T. Sagawa, R. Arai, S. Inoue, H. Yamaguchi, and S. Abe Therapeutic effects on murine oral candidiasis by oral administration of cassia (Cinnamomum cassia) preparation Nippon Ishinkin Gakkai Zasshi 51 2010 13 21
46. J.M. Quale, D. Landman, M.M. Zaman, S. Burney, and S.S. Sathe In vitro activity of Cinnamomum zeylanicum against azole resistant and sensitive Candida species and a pilot study of cinnamon for oral candidiasis Am. J. Chin. Med. 24 1996 103 109
47. U. Julnar, K. Sawsan, B. Pascale, B.M. Yolla, and N.C. Hania Comparative study on the effect of Cinnamaon and clove extracts and their main components on different types of ATPases Hum. Exp. Toxicol. 22 2003 335 362
48. K.H. Bang, D.W. Lee, H.M. Park, and Y.H. Rhee Inhibition of fungal cell wall synthesizing enzymes by trans-cinnamaldehyde Biosci. Biotechnol. Biochem. 64 2000 1061 1063
49. X.M. Xie, J.R. Fang, and Y. Xu Study of antifungal effect of cinnamaldehyde and citral on Aspergillus flavus Food Sci. 25 2004 32 34
50. M. Ghannoum, and L.B. Rice Antifungal agents: mode of action, mechanism of resistance, and correlation of these mechanisms with bacterial resistance Clin. Microbiol. Rev. 12 1999 501 512
51. R. Franz, S.L. Kelly, D.C. Lamb, D.E. Kelly, M. Ruhnke, and J. Morschhauser Multiple molecular mechanisms contribute to a stepwise development of fluconazole resistance in clinical Candida albicans strains Antimicrob. Agents Chemother. 42 1998 3065 3072
52. H. Bernhardt, K. Zimmermann, and M. Knoke Fungal resistance Infection 27 1999 52 54
53. D. Ellis Amphotericin B: spectrum and resistance J. Antimicrob. Chemother. 49 2002 7 10
54. R.L. Laborin, and M.N. Vargas Amphotericin B: side effects and toxicity Rev. Iberoam. Micol. 26 2009 223 227
55. C.I. Bagnis, and G. Deray Amphotericin B nephrotoxicity Saudi J. Kidney Dis. Transpl. 13 2002 481 491
56. J.S. Daniel, A.H. Christopher, and M.S. Carol Current and emerging azole antifungal agents Clin. Microbiol. Rev. 12 1999 40 79
57. G.V. Minnebruggen, I.E.J.A. Francois, B.P.A. Cammue, K. Thevissen, V. Vroome, M. Borgers, and B.A. Shroot General overview on past, present and future antimycotics Open Mycol. J. 4 2010 22 32
58. M.A. Pfaller, G.J. Moet, S.A. Messer, R.N. Jones, and M. Castanheira Candida bloodstream infections: comparison of species distributions and antifungal resistance patterns in community-onset and nosocomial isolates in the SENTRY Antimicrobial Surveillance Program, 2008-2009 Antimicrob. Agents Chemother. 55 2011 561 566
59. D.A. Stevens, M. Ichinomiya, Y. Koshi, and H. Horiuchi Escape of Candida from Caspofungin inhibition at concentrations above the MIC (paradoxical effect) accomplished by increased cell wall chitin; evidence for β-1,6-glucan synthesis inhibition by Caspofungin Chemotherapy 50 2006 3160 3161
60. D.W. Denning, C.C. Kibbler, and R.A. Barnes British Society for Medical Mycology proposed standards of care for patients with invasive fungal infections Lancet Infect. Dis. 3 2003 230 240
61. K.V. Peter Handbook of Herbs and Spices Vols. 143-53 2001 Woodhead Publishing
62. V. Jakhetia, R. Patel, P. Khatri, N. Pahuja, S. Garg, A. Pandey, and S. Sharma Cinnamaon: a pharmacological review J. Adv. Sci. Res. 1 2010 19 23
63. A. Sangal Role of cinnamon as beneficial antidiabetic food adjunct: a review Adv. Appl. Sci. Res. 2 2011 440 450
64. M. Vangalapati, N.S. Satya, D.S. Prakash, and S. Avanigadda A review on pharmacological activities and clinical effects of cinnamon species Res. J. Pharm.; Biol. Chem. Sci. 3 2012 653 663
65. Y.C. Wong, M.Y. Ahmad-Mudzaqqir, and W.A. Wan-Nu Extraction of essential oil from cinnamon (Cinnamomum zeylanicum) Orient. J. Chem. 30 2014 37 47
66. L.S. Ooi, Y. Li, S.L. Kam, H. Wang, E.Y. Wong, and V.E. Ooi Antimicrobial activities of cinnamon oil and cinnamaldehyde from the Chinese medicinal herb Cinnamomum cassia Blume Am. J. Chin. Med. 34 2006 511 522
67. R. Li, Y. Wang, J. Zi-Tao, and J. Shan Chemical composition of the essential oils of Cinnamomum loureirii Nees. From China obtained by hydrodistillation and microwave-assisted hydrodistillation J. Essent. Oil Res. 22 2010 129 131
68. U.T.P. Sylvia, L.L. Ellen, W. Sandra de, I. Rinaldi, H. Triana, and V.H. Cees Effect of Cinnamomum burmannii Nees ex Bl. and Massoia aromatica Becc. essential oils on planktonic growth and biofilm formation of Pseudomonas aeruginosa and Staphylococcus aureus in vitro Int. J. Appl. Res. Nat. Prod. 8 2015 1 13
69. H. Lohani, C.A. Harish, N. Chauhan, and U. Bhandari Variability in volatile constituents of Cinnamomum tamala leaf from Uttarakhand Himalaya Asian Pac. J. Trop. Biomed. 2012 S667 S669
70. S.Y. Wang, C.W. Yang, J.W. Liao, W.W. Zhen, F.H. Chu, and S.T. Chang Essential oil from leaves of Cinnamomum osmophloeum acts as a xanthine oxidase inhibitor and reduces the serum uric acid levels in oxonate-induced mice Phytomedicine 15 2008 940 945
71. Y.T. Tung, M.T. Chua, S.W. Wang, and S.T. Chang Anti-inflammation activities of essential oil and its constituents from indigenous cinnamon (Cinnamomum osmophloeum) twigs Bioresour. Technol. 99 2008 3908 3913
72. U.M. Senanayake, R.B.H. Wills, and T.H. Lee Biosynthesis of eugenol and cinnamic aldehyde in Cinnamomum zeylanicum Phytochemistry 16 1977 2032 2033
73. H.F. Yeh, C.Y. Luo, C.Y. Lin, S.S. Cheng, Y.R. Hsu, and S.T. Chang Methods for thermal stability enhancement of leaf essential oils and their main constituents from indigenous cinnamon (Cinnamomum osmophloeum) J. Agric. Food Chem. 61 2013 6293 6298
74. C.W. Chang, W.L. Chang, S.T. Chang, and S.S. Cheng Antibacterial activities of plant essential oils against Legionella pneumophila Water Res. 42 2008 278 286
75. 2 extract of Cinnamomum zeylanicum: chemical characterization and antityrosinase activity J. Agric. Food Chem. 55 2007 1022 1027
76. S.T. Chou, W.L. Chang, C.T. Chang, S.L. Hsu, Y.C. Lin, and Y. Shih Cinnamomum cassia essential oil inhibits α-MSH-induced melanin production and oxidative stress in murine B16 melanoma cells Int. J. Mol. Sci. 14 2013 (19186-01)
77. N. Hossein, Z. Zahra, M. Abolfazl, S. Mahdi, and K. Ali Effect of Cinnamon zeylanicum essence and distillate on the clotting time J. Med. Plant Res. 7 2013 1339 1343
78. S. Minich, and L. Msom Chinese herbal medicine in women's health Womens Health 2008
79. M. Narumol, and M. Nirundorn Effect of combined cinnamon and clove oil against major moulds identified from rubberwood (Heveabrasiliensis) Walailak J. Sci. Technol. 4 2007 165 174
80. S.Y. Wang, and S.T. Chang Antifungal activities of essential oils and their constituents from indigenous cinnamon (Cinnamomum osmophloeum) leaves against wood decay fungi Bioresour. Technol. 96 2005 813 818
81. B.J. Ibrahim, A.K.M. Bushra, S. Jacintha, and A.J. Jamia Correlation between chemical composition and antifungal activity of the essential oils of eight cinnamomum species Pharm. Biol. 46 2008 406 412
82. R. Atta-ur, C.M. Iqbal, F. Afgan, A. Aftab, I.M. Zafar, D. Betul, and C.B. Husnu Antifungal activities and essential oil constituents of some spices from Pakistan J. Chem. Soc. Pak. 22 2000 60 65
83. U. Mehmet, E. Emel, V.U. Gulhan, S.Z. Hulya, and V. Nilufer Composition, antimicrobial activity and in vitro cytotoxicity of essential oil from Cinnamomum zeylanicum Blume (Lauraceae) Food Chem. Toxicol. 48 2010 3274 3280
84. O. Mounia, C. Stephane, S. Linda, and L. Monique Inhibitory efects of selected plant essential oils on the growth of four pathogenic bacteria: E. coli O157:H7, Salmonella Typhimurium, Staphylococcus aureus and Listeria monocytogenes Food Control 18 2007 414 420
85. P. Hili, C.S. Evans, and R.G. Veness Antimicrobial action of essential oils: the effect of dimethylsulphoxide on the activity of cinnamon oil Lett. Appl. Microbiol. 24 1997 269 275
86. N. Matan, H. Rimkeeree, A.J. Mawson, P. Chompreeda, V. Haruthaithanasan, and M. Parker Antimicrobial activity of cinnamon and clove oils under modified atmosphere conditions Int. J. Food Microbiol. 107 2006 180 185
87. L.B. Gende, I. Floris, R. Fritz, and M.J.B. Eguaras Antimicrobial activity of cinnamon (Cinnamomum zeylanicum) essential oil and its main components against paenibacillus larvae from argentine Insectol 61 2008 1 4
88. R. Becerril, R. Gomez-Lus, P. Goni, P. Lopez, and C. Nerin Combination of analytical and microbiological techniques to study the antimicrobial activity of a new active food packaging containing cinnamon or oregano against E. coli and S. aureus Anal. Bioanal. Chem. 388 2007 1003 1011
89. P. Goni, P. Lopez, C. Sanchez, L.R. Gomez, R. Becerril, and C. Nerin Antimicrobial activity in the vapour phase of a combination of cinnamon and clove essential oils Food Chem. 116 2009 982 989
90. H. Parthasarathy, and S. Thombare Evaluation of antimicrobial activity of Azadirachtaindica, Syzygiumaromaticum and Cinnamomum zeyalnicum against oral microflora Asian J. Exp. Sci. 27 2013 13 16
91. K. Hayashi, N. Imanishi, Y. Kashiwayama, A. Kawanod, K. Terasawa, Y. Shimada, and H. Ochiai Inhibitory effect of cinnamaldehyde, derived from cinnamomi cortex, on the growth of influenza A/PR/8 virus in vitro and in vivo Antivir. Res. 74 2007 1 8
92. L. Lei, W. Feng-xiang, Q. Zhang-yi, W. Shu-qiu, C. Guang, G. Hong, Z. Hong-yan, S. Lei, Y. Xiao-hui, and W. Ying-chen The anti-adenovirus activities of cinnamaldehyde in vitro Lab. Med. 40 2009 669 674
93. M. Tabak, R. Armon, and I. Neeman Cinnamon extracts inhibitory effect on Helicobacter pylori J. Ethnopharmacol. 67 1999 269 277
94. F.J. Mancini, K.A. Van, D.A.P. Mancini, F.F. Cozzolino, and R.P. Torres Antioxidant activity of cinnamon (Cinnamomum zeylanicum, breyne) extracts Boll. Chim. Farm. 137 1998 443 447
95. S. Shobana, and N.K. Akhilender Antioxidant activity of selected Indian spices Prostaglandins Leukot. Essent. Fatty Acids 62 2000 107 110
96. S. Mathew, and T.E. Abraham Studies on the antioxidant activities of cinnamon (Cinnamomum verum) bark extracts, through various in vitro models Food Chem. 94 2006 520 528
97. N. Kim, H. Sung, and W. Kim Effect of solvents and some extraction conditions on antioxidant activity in cinnamon extracts Korean J. Food Sci. Technol. 25 1993 204 209
98. S.H. Kim, S.H. Hyun, and S.Y. Choung Anti-diabetic effect of cinnamon extract on blood glucose in db/db mice J. Ethnopharmacol. 104 2006 119 123
99. S. Prabuseenivasan, M. Jayakumar, and S. Ignacimuthu In vitro antibacterial activity of some plant essential oils BMC Complement. Altern. Med. 6 2006 1 8
100. Q. Jia, X. Liu, X. Wu, and et al. Hypoglycemic activity of a polyphenolic oligomer-rich extract of Cinnamomum parthenoxylon bark in normal and streptozotocin-induced diabetic rats Phytomedicine 16 2009 744 750
101. K.J. Jarvill-Taylor, R.A. Anderson, and D.J. Graves A hydroxychalcone derived from cinnamon functions as a mimetic for insulin in 3T3-L1 adipocytes J. Am. Coll. Nutr. 20 2001 327 336
102. Z. Lu, Q. Jia, R. Wang, and et al. Hypoglycemic activities of A- and B-type procyanidin oligomer-rich extracts from different cinnamon barks Phytomedicine 18 2011 (298-02)
103. B.P. Subash, S. Prabuseenivasan, and S. Ignacimuthu Cinnamaldehyde - a potential antidiabetic agent Phytomedicine 14 2007 15 22
104. K. Im, A. Issac, J. Nm, E. Ninan, B. Maliakel, and R. Kuttan Effects of the polyphenol content on the anti-diabetic activity of Cinnamomum zeylanicum extracts Food Funct. 5 2014 2208 2220
105. S. Onderoglu, S. Sozer, K.M. Erbil, R. Ortac, and F. Lermioglu The evaluation of long-term effects of cinnamon bark and olive leaf on toxicity induced by streptozotocin administration to rats J. Pharm. Pharmacol. 51 1999 1305 1312
106. L.K. Chao, K.F. Hua, H.Y. Hsu, S.S. Cheng, J.Y. Liu, and S.T. Chang Study on the anti-inflammatory activity of essential oil from leaves of Cinnamomum osmophloeum J. Agric. Food Chem. 53 2005 7274 7278
107. Y.T. Tung, P.L. Yen, C.Y. Lin, and S.T. Chang Anti-inflammatory activities of essential oils and their constituents from different provenances of indigenous cinnamon (Cinnamomum osmophloeum) leaves Pharm. Biol. 48 2010 1130 1136
108. J. Lu, K. Zhang, S. Nam, R.A. Anderson, R. Jove, and W. Wen Novel angiogenesis inhibitory activity in cinnamon extract blocks VEGFR2 kinase and downstream signaling Carcinogenesis 31 2010 481 488
109. + T cells Cancer Lett. 278 2009 174 182
110. H.K. Kwon, J.S. Hwang, J.S. So, C.G. Lee, A. Sahoo, J.H. Ryu, W.K. Jeon, B.S. Ko, C.R. Im, S.H. Lee, Z.Y. Park, and S.H. Im Cinnamon extract induces tumor cell death through inhibition of NFκB and AP1 BMC Cancer 10 2010 392 397
111. S.J. Koppikar, A.S. Choudhari, S.A. Suryavanshi, S. Kumari, S. Chattopadhyay, and R. Kaul-Ghanekar Aqueous cinnamon extract (ACE-c) from the bark of Cinnamomum cassia causes apoptosis in human cervical cancer cell line (SiHa) through loss of mitochondrial membrane potential BMC Cancer 10 2010 210
112. G.T. Wondrak, N.F. Villeneuve, S.D. Lamore, A.S. Bause, T. Jiang, and D.D. Zhang The cinnamon-derived dietary factor cinnamic aldehyde activates the Nrf2-dependent antioxidant response in human epithelial colon cells Molecules 15 2010 3338 3355
113. I.K. Park, J.Y. Park, K.H. Kim, and et al. Nematicidal activity of plant essential oils and components from garlic (Allium sativum) and cinnamon (Cinnamomum verum) oils against the pine wood nematode (Bursaphelenchus xylophilus) Nematology 7 2005 767 774
114. J.O. Kong, S.M. Lee, Y.S. Moon, S.G. Lee, and Y.J. Ahn Nematicidal activity of cassia and cinnamon oil compounds and related compounds toward Bursaphelenchus xylophilus (Nematoda: Parasitaphelenchidae) J. Nematol. 39 2007 31 36
115. S.S. Cheng, J.Y. Liu, K.H. Tsai, W.J. Chen, and S.T. Chang Chemical composition and mosquito larvicidal activity of essential oils from leaves of different Cinnamomum osmophloeum provenances J. Agric. Food Chem. 52 2004 4395 4400
116. S.S. Cheng, J.Y. Liu, C.G. Huang, Y.R. Hsui, W.J. Chen, and S.T. Chang Insecticidal activities of leaf essential oils from Cinnamomum osmophloeum against three mosquito species Bioresour. Technol. 100 2009 457 464
117. V. Dhulasavant, S. Shinde, M. Pawar, and N.S. Naikwade Antihyperlipidemic activity of Cinnamomum tamala Nees. on high cholesterol diet induced hyperlipidemia Int. J. Pharm. Tech. Res. 2 2010 2517 2521
118. K.A. Amin, and T.M.A. El-Twab Oxidative markers, nitric oxide and homocysteine alteration in hypercholesterolimic rats: role of atorvastatine and cinnamon Int. J. Clin. Exp. Med. 2 2009 254 265
119. T. Bandara, I. Uluwaduge, and E.R. Jansz Bioactivity of cinnamon with special emphasis on diabetes mellitus: a review Int. J. Food Sci. Nutr. 63 2012 380 386
120. J.S. Hwa, Y.C. Jin, Y.S. Lee, and et al. 2-methoxycinnamaldehyde from Cinnamomum cassia reduces rat myocardial ischemia and reperfusion injury in vivo due to HO-1 induction J. Ethnopharmacol. 139 2012 605 615
121. F. Song, H. Li, J. Sun, and S. Wang Protective effects of cinnamic acid and cinnamic aldehyde on isoproterenol-induced acute myocardial ischemia in rats J. Ethnopharmacol. 150 2013 125 130
122. S. Rahman, H. Begum, Z. Rahman, F. Ara, M.J. Iqbal, and A.K.M. Yousuf Effect of cinnamon (Cinnamomum cassia) as a lipid lowering agent on hypercholesterolemic rats J. Enam Med. Coll. 3 2013 94 98
123. M. Ciftci, U.G. Simsek, A. Yuce, O. Yilmaz, and B. Dalkilic Effects of dietary antibiotic and cinnamon oil supplementation on antioxidant enzyme activities, cholesterol levels and fatty acid compositions of serum and meat in broiler chickens Acta Vet. Brno 79 2010 33 40
124. A. Khan, M. Safdar, M.M.A. Khan, K.N. Khattak, and R.A. Anderson Cinnamon improves glucose and lipids of people with type 2 diabetes Diabetes Care 26 2003 3215 3218
125. K. Aneja, R. Joshi, and C. Sharma Antimicrobial activity of dalchini (Cinnamomum zeylanicum bark) extracts on some dental caries pathogens J. Pharm. Res. 2 2009 1387 1390
126. C. Gupta, A. Kumari, A.P. Garg, R. Catanzaro, and F. Marotta Comparative study of cinnamon oil and clove oil on some oral microbiota Acta Biol. Med. 82 2011 197 199
127. V. Jakhetia, R. Patel, and P. Khatri Cinnamon: a pharmacological review J. Adv. Sci. Res. 1 2010 (19-12)
128. W. Blakemore, and H. Thompson Trace analysis of cinnamaldehyde in animal feed, human urine, and wastewater by electron capture gas chromatography J. Agric. Food Chem. 3 1983 1047 1052
129. J.B. Dumas, and E. Peligot Sur l'Huile de Cannelle, l'Acide Hippurique, et l'Acide Sebacique Ann. Chim. Phys. 57 1834 305 334
130. L. Chiozza Surla production artificielle de l'essence de cannelle Comptes rendus 1 1856 222f
131. Y. Huang, and S.H. Ho Toxicity and antifeedant activities of cinnamaldehyde against the grain storage insects, Tribolium castaneum (Herbst) and Sitophilus zeamais Motsch J. Stored Prod. Res. 34 1988 11 17
132. R.S. Sadhna, R.S. Libin, Z. Javier, R.G. Bibiana, L. Lynn, and F. Mendel Carvacrol and cinnamaldehyde inactivate antibiotic-resistant Salmonella enterica in buffer and on celery and oysters J. Food Prot. 73 2010 234 240
133. M. Demo, M. Oliva, B. Ramos, and J. Zigadlo Determination of the antibacterial activity of the pure components of essential oils Hig. Aliment. 85 2001 87 90
134. J.A. Kwon, C.B. Yu, and H.D. Park Bactericidal effects and inhibition of cell separation of cinnamic aldehyde on Bacillus cereus Lett. Appl. Microbiol. 37 2003 61 65
135. B.C. Liao, C.W. Hsieh, Y.C. Liu, T.T. Tzeng, Y.W. Sun, and B.S. Wung Cinnamaldehyde inhibits the tumor necrosis factor-α-induced expression of cell adhesion molecules in endothelial cells by suppressing NF-κB activation: effects upon IκB and Nrf2 Toxicol. Appl. Pharmacol. 229 2008 161 171
136. W.S. Koh, S.Y. Yoon, B.M. Kwon, T.C. Jeong, K.S. Nam, and M.Y. Han Cinnamaldehyde inhibits lymphocyte proliferation and modulates T cell differentiation Int. J. Immunopharmacol. 20 1998 643 660
137. T. Imai, K. Yasuhara, T. Tamura, T. Takizawa, M. Ueda, M. Hirose, and K. Mitsumori Inhibitory effects of cinnamaldehyde on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung carcinogenesis in rasH2 mice Cancer Lett. 175 2002 9 16
138. B.M. Kwon, S.H. Lee, Y.K. Cho, S.H. Bok, S.H. So, and M.R. Youn Synthesis and biological activity of cinnamaldehydes as angiogenesis inhibitors Bioorg. Med. Chem. Lett. 7 1997 2473 2476
139. F. Shih-Hua, K.R. Yerra, and T. Yew-Min Cytotoxic effect of trans-cinnamaldehyde from Cinnamomum osmophloeum leaves on human cancer cell lines Int. J. Appl. Sci. Eng. 2 2004 136 147
140. S.J. Wu, L.T. Ng, and C.C. Lin Cinnamaldehyde-induced apoptosis in human PLC/PRF/5 cells through activation of the proapoptotic Bcl-2 family proteins and MAPK pathway Life Sci. 77 2005 938 951
141. M.C. Christopher, B.B. Warner, D.L. Sarah, L. Stephanie, S.B. Alexandra, A. Sara, and T.W. Georg The cinnamon-derived michael acceptor cinnamic aldehyde impairs melanoma cell proliferation, invasiveness, and tumor growth Free Radic. Biol. Med. 46 2009 220 231
142. A.M. Reddy, J.H. Seo, S.Y. Ryu, Y.S. Kim, Y.S. Kim, K.R. Min, and Y. Kim Cinnamaldehyde and 2-methoxycinnamaldehyde as NF kappaB inhibitors from Cinnamomum cassia Planta Med. 70 2004 823 827
143. C.M. Cabello, W.B. Bair, S.D. Lamore, S. Ley, A.S. Bause, S. Azimian, and G.T. Wondrak The cinnamon-derived Michael acceptor cinnamic aldehyde impairs melanoma cell proliferation, invasiveness, and tumor growth Free Radic. Biol. Med. 15 46 2009 220 231
144. J.Y. Guo, H.R. Huo, B.S. Zhao, H.B. Liu, L.F. Li, Y.Y. Ma, S.Y. Guo, and T.L. Jiang Cinnamaldehyde reduces IL-1beta-induced cyclooxygenase-2 activity in rat cerebral microvascular endothelial cells Eur. J. Pharmacol. 537 2006 174 180
145. P. Anand, K.Y. Murali, V. Tandon, P.S. Murthy, and R. Chandra Insulinotropic effect of cinnamaldehyde on transcriptional regulation of pyruvate kinase, phosphoenolpyruvate carboxykinase, and GLUT4 translocation in experimental diabetic rats Chem. Biol. Interact. 186 2010 72 81
146. S.H. Fang, K.R. Yerra, and T. Yew-Min Cytotoxic effect of trans-cinnamaldehyde from cinnamomum osmophloeum leaves on human cancer cell lines Int J Appl Scie Eng 2004 136 147
147. L.T. Lin, C.J. Tai, S.P. Chang, J.L. Chen, S.J. Wu, and C.C. Lin Cinnamaldehyde-induced apoptosis in human hepatoma PLC/PRF/5 cells involves the mitochondrial death pathway and is sensitive to inhibition by cyclosporin a and z-VAD-fmk Anti Cancer Agents Med. Chem. 13 2013 1565 1574
148. B.J. Chen, C.S. Fu, G.H. Li, X.N. Wang, H.X. Lou, D.M. Ren, and T. Shen Cinnamaldehyde analogues as potential therapeutic agents Mini Rev. Med. Chem. 2016 (Epub ahead of print)
149. N. Anneli, B. Christofer, A. Mounir, M.J. Anna, L.M. Sherry, K. Anders, and L. Mats Synthesis of functionalized cinnamaldehyde derivatives by an oxidative heck reaction and their use as starting materials for preparation of Mycobacterium tuberculosis 1-deoxy-d-xylulose-5-phosphate reductoisomerase inhibitors J. Organomet. Chem. 76 2011 8986 8998
150. X. Li, J. Sheng, G. Huang, R. Ma, F. Yin, D. Song, C. Zhao, and S. Ma Design, synthesis and antibacterial activity of cinnamaldehyde derivatives as inhibitors of the bacterial cell division protein FtsZ Eur. J. Med. Chem. 97 2015 32 41
151. G. Brackman, S. Celen, U. Hillaert, S. Van Calenbergh, P. Cos, L. Maes, H.J. Nelis, and T. Coenye Structure-activity relationship of cinnamaldehyde analogs as inhibitors of AI-2 based quorum sensing and their effect on virulence of vibrio spp PLoS One 6 2011 e16084
152. S. Andrade-Ochoa, G.V. Nevarez-Moorillon, L.E. Sanchez-Torres, M. Villanueva-Garcia, B.E. Sanchez-Ramirez, L.M. Rodriguez-Valdez, and B.E. Rivera-Chavira Quantitative structure-activity relationship of molecules constituent of different essential oils with antimycobacterial activity against Mycobacterium tuberculosis and Mycobacterium bovis BMC Complement. Altern. Med. 15 2015 332
153. Q. Sun, B. Shang, L. Wang, Z. Lu, and Y. Liu Cinnamaldehyde inhibits fungal growth and aflatoxin B1 biosynthesis by modulating the oxidative stress response of Aspergillus flavus Appl. Microbiol. Biotechnol. 100 2016 1355 1364
154. M. Homa, I.P. Fekete, A. Böszörményi, Y.R. Singh, K.P. Selvam, C.S. Shobana, P. Manikandan, L. Kredics, C. Vágvölgyi, and L. Galgóczy Antifungal effect of essential oils against Fusarium keratitis isolates Planta Med. 81 2015 1277 1284
155. H. Li, Q. Shen, W. Zhou, H. Mo, D. Pan, and L. Hu Nanocapsular dispersion of cinnamaldehyde for enhanced inhibitory activity against aflatoxin production by Aspergillus flavus Molecules 20 2015 6022 6032
156. A.N. Aziz, H. Ibrahim, D. Rosmy Syamsir, M. Mohtar, J. Vejayan, and K. Awang Antimicrobial compounds from Alpinia conchigera J. Ethnopharmacol. 145 2013 798 802
157. M. Valero, and E. Francés Synergistic bactericidal effect of carvacrol, cinnamaldehyde or thymol and refrigeration to inhibit Bacillus cereus in carrot broth Food Microbiol. 23 2006 68 73
158. M. Kyo, G. Manabu, F. Tokio, and Y. Kei Toxicity of allylisothiocyanate and cinnamic aldehyde assessed using cultured human KB cells and yeast, Saccharomyces cervisiae Bull. Environ. Contam. Toxicol. 40 1988 339 342
159. M. Narumol Growth inhibition of Aspergillus niger by cinnamaldehyde and eugenol J. Sci. Technol. 4 2007 41 51
160. M. Hideaki, I.I. Yoshikazu, T. Yukihiro, and T. Tohru Evaluation of antifungal volatile compounds on the basis of the elongation rate of a single hypha Appl. Environ. Microbiol. 56 1990 3779 3784
161. J.S. Raut, R.B. Shinde, N.M. Chauhan, and S.M. Karuppayil Phenylpropanoids of plant origin as inhibitors of biofilm formation by Candida albicans J. Microbiol. Biotechnol. 24 2014 1216 1225
162. L. Han-Chung, C. Sen-Sung, and C. Shang-Tzen Antifungal property of the essential oils and their constituents from Cinnamomum osmophloeum leaf against tree pathogenic fungi J. Sci. Food Agric. 85 2005 2047 2053
163. S.S. Cheng, J. Liu, E. Chang, and S.T. Chang Antifungal activity of cinnamaldehyde and eugenol congeners against wood-rot fungi Bioresour. Technol. 99 2008 5145 5149
164. S. Shreaz, R. Bhatia, N. Khan, S. Muralidhar, S.F. Basir, N. Manzoor, and L.A. Khan Spice oil cinnamaldehyde exhibits potent anticandidal activity against fluconazole resistant clinical isolates Fitoterapia 82 2011 1012 1020
165. S. Shreaz, R. Bhatia, N. Khan, I.K. Maurya, S.I. Ahmad, M. Nikhat, S. Muralidhar, and L.A. Khan Cinnamic aldehydes affect hydrolytic enzyme secretion and morphogenesis in oral Candida isolates Microb. Pathog. 52 2012 251 258
166. S. Shreaz, R. Bhatia, N. Khan, S. Muralidhar, N. Manzoor, and L.A. Khan Influences of cinnamic aldehydes on H extrusion activity and ultrastructure of Candida J. Med. Microbiol. 62 2013 232 240
167. M.P. Balaguer, G. Lopez-Carballo, R. Catala, R. Gavara, and P. Hernandez-Munoz Antifungal properties of gliadin films incorporating cinnamaldehyde and application in active food packaging of bread and cheese spread foodstuffs Int. J. Food Microbiol. 166 2013 369 377
168. M.P. Balaguer, P. Fajardo, H. Gartner, J. Gomez-Estaca, R. Gavara, E. Almenar, and P. Hernandez-Munoz Functional properties and antifungal activity of films based on gliadins containing cinnamaldehyde and natamycin Int. J. Food Microbiol. 173 2014 62 71
169. R. Diyardokht, B. Neda, K. Sohrab, A.A.S. Seyyed, and A.M. Ali An in vitro study of the effect of cinnamaldehyde on the growth of Candida albicans compared to nystatin and fluconazole Crescent J. Med. Biol. Sci. 2 2015 76 80
170. M. Khan, A. Sajjad, A. Malik, and I. Ahmad Anti-candidal activity of essential oils alone and in combination with amphotericin B or fluconazole against multi-drug resistant isolates of Candida albicans Med. Mycol. 50 2012 33 42
171. S.A.K. Mohd, and A. Iqbal Antibiofilm activity of certain phytocompounds and their synergy with fluconazole against Candida albicans biofilms J. Antimicrob. Chemother. 67 2012 618 621
172. R. Di Pasqua, G. Betts, N. Hoskins, M. Edwards, D. Ercolini, and G. Mauriello Membrane toxicity of antimicrobial compounds from essential oils J. Agric. Food Chem. 55 2007 4863 4870
173. R. Di Pasqua, N. Hoskins, G. Betts, and G. Mauriello Changes in membrane fatty acids composition of microbial cells induced by addiction of thymol, carvacrol, limonene, cinnamaldehyde, and eugenol in the growing media J. Agric. Food Chem. 54 2006 2745 2749
174. S. Shreaz, R.A. Shiekh, V. Raja, W.A. Wani, and J.M. Behbehani Impaired ergosterol biosynthesis mediated fungicidal activity of Co(II) complex with ligand derived from cinnamaldehyde Chem. Biol. Interact. 247 2016 64 74
175. A.O. Gill, and R.A. Holley Disruption of Escherichia coli, Listeria monocytogenes and Lactobacillus sakei cellular membranes by plant oil aromatics Int. J. Food Microbiol. 108 2006 1 9
176. A.O. Gill, and R.A. Holley Inhibition of membrane bound ATPases of Escherichia coli and Listeriamonocytogenes by plant oil aromatics Int. J. Food Microbiol. 111 2006 170 174
177. 2 + efflux is involved in cinnamaldehyde-induced growth inhibition of Phytophthora capsici PLoS One 8 2013 e76264
178. W.E. Courchesne, M. Tunc, and S. Liao Amiodarone induces stress responses and calcium flux mediated by the cell wall in Saccharomyces cerevisiae Can. J. Microbiol. 55 2009 288 303
179. 2 + in an additive manner in dopaminergic PC12 cells Toxicol. Sci. 134 2013 374 381
180. S. Liu, Y. Hou, W. Liu, C. Lu, W. Wang, and S. Sun Components of the calcium-calcineurin signaling pathway in fungal cells and their potential as antifungal targets Eukaryot. Cell 14 2015 324 334
181. A. Brand, S. Shanks, V.M. Duncan, M. Yang, K. Mackenzie, and N.A. Gow Hyphal orientation of Candida albicans is regulated by a calcium-dependent mechanism Curr. Biol. 17 2007 347 352
182. C.N. Wendakoon, and S. Morihiko Inhibition of amino acid decarboxylase activity of Enterobacteraerogenes by active components in spices J. Food Prot. 58 1995 280 283
183. N. Yossa, J. Patel, P. Millner, S. Ravishankar, and Y.M. Lo Antimicrobial activity of plant essential oils against Escherichia coli O157:H7 and Salmonella on lettuce Foodborne Pathog. Dis. 10 2013 87 96
184. A. Ultee, E.P. Kets, and E.J. Smid Mechanisms of action of carvacrol on the food-borne pathogen Bacillus cereus Appl. Environ. Microbiol. 65 1999 4606 4610
185. S.B. Rajput, and S.M. Karuppayil Small molecules inhibit growth, viability and ergosterol biosynthesis in Candida albicans Springerplus 2 2013 26
186. M.S. Khan, I. Ahmad, and S.S. Cameotra Phenyl aldehyde and propanoids exert multiple sites of action towards cell membrane and cell wall targeting ergosterol in Candida albicans AMB Express 3 2013 54
187. L.W. Parks, and W.M. Casey Physiological implications of sterol biosynthesis in yeast Annu. Rev. Microbiol. 49 1995 95 116
188. F. Abe, and T. Hiraki Mechanistic role of ergosterol in membrane rigidity and cycloheximide resistance in Saccharomyces cerevisiae Biochim. Biophys. Acta 2009 1788 743 752
189. B.C. Monk, and D.S. Perlin Fungal plasma membrane proton pumps as promising new antifungal targets Crit. Rev. Microbiol. 20 1994 209 223
190. R. Serrano Structure and function of proton translocating ATPase in plasma membranes of plants and fungi Biochim. Biophys. Acta 947 1988 1 28
191. R. Prasad Nutrient transport in Candida albicans, a pathogenic yeast Yeast 3 1987 209 221
192. P. Domadia, S. Swarup, A. Bhunia, J. Sivaraman, and D. Dasgupta Inhibition of bacterial cell division protein FtsZ by cinnamaldehyde Biochem. Pharmacol. 74 2007 831 840
193. S. Hemaiswarya, R. Soudaminikkutty, M.L. Narasumani, and M. Doble Phenylpropanoids inhibit protofilament formation of Escherichia coli cell division protein FtsZ J. Med. Microbiol. 60 2011 1317 1325
194. N. Rastogi, P. Domadia, S. Shetty, and D. Dasgupta Screening of natural phenolic compounds for potential to inhibit bacterial cell division protein FtsZ Indian J. Exp. Biol. 46 2008 783 787
195. L. Romberg, M. Simon, and H.P. Erickson Polymerization of FtsZ, a bacterial homolog of tubulin: is assembly cooperative? J. Biol. Chem. 276 2001 11743
196. L. Romberg, and P.A. Levin Assembly dynamics of the bacterial cell division protein FtsZ: poised at the edge of stability Annu. Rev. Microbiol. 57 2003 125
197. J. Errington, R.A. Daniel, and D.-J. Scheffers Cytokinesis in bacteria Microbiol. Mol. Biol. Rev. 67 2003 52
198. T.H. Kang, E.I. Hwang, B.S. Yun, K.D. Park, B.M. Kwon, C.S. Shin, and S.U. Kim Inhibition of chitin synthases and antifungal activities by 2′-benzoyloxycinnamaldehyde from Pleuropterusciliinervis and its derivatives Biol. Pharm. Bull. 30 2007 (598-02)
199. N. Khan, S. Shreaz, R. Bhatia, S.I. Ahmad, S. Muralidhar, N. Manzoor, and L.A. Khan Anticandidal activity of curcumin and methyl cinnamaldehyde Fitoterapia 83 2012 434 440
200. Q.Y. Wei, J.J. Xiong, H. Jiang, C. Zhang, and Y. Wen The antimicrobial activities of the cinnamaldehyde adducts with amino acids Int. J. Food Microbiol. 150 2011 164 170
201. R. Bhatia, S. Shreaz, N. Khan, S. Muralidhar, S.F. Basir, N. Manzoor, and L.A. Khan Proton pumping ATPase mediated fungicidal activity of two essential oil components J. Basic Microbiol. 52 2012 504 512
202. K.H. Bang, B.S. Min, and Y.H. Rhee Antifungal activity of cinnamaldehyde derivatives Korean J. Mycol. 26 1998 525 530
203. Z. Jiang, H. Jiang, and P. Xie Antifungal activities against Sclerotiniasclerotiorum by Cinnamomum cassia oil and its main components J. Essent. Oil Res. 25 2013 95 401
204. M. Satoshi Isolation purification and antibiotic activity of o-methoxycinnamaldehyde from cinnamon Appl. Microbiol. 36 1978 577 583
205. S. Ishida, A. Matsuda, Y. Kawamura, and K. Yamanaka Antifungal agent. I. Antibacterial and antifungal activities in vitro of several organic compounds. II. Antibacterial and antifungal activities of cinnamaldehyde derivatives. III. Antibacterial and antifungal activities of a-bromo cinnamaldehyde derivatives Chemother. Tokyo 8 1960 146 159
206. M.E.I. Badawy, S.M. Ahmed, and E.I. Rabea Bactericidal and fungicidal activities of different molecular weight chitosan samples J. Pest Control Environ. Sci. 14 2006 19 34
207. I.M. Helander, E.L. Nurmiaho-Lassila, R. Ahvenainen, J. Rhoades, and S. Roller Chitosan disrupts the barrier properties of the outer membrane of gram-negative bacteria Int. J. Food Microbiol. 71 2001 235 244
208. G.H. Wang Inhibition and inactivation of five species of foodborne pathogens by chitosan J. Food Prot. 55 1992 916 919
209. M.E. Badawy, and E.I. Rabea Synthesis and structure-activity relationship of N-(cinnamyl) chitosan analogs as antimicrobial agents Int. J. Biol. Macromol. 57 2013 185 192
210. I. Ali, W.A. Wani, K. Saleem, and A. Haque Platinum compounds: a hope for future cancer chemotherapy Anti Cancer Agents Med. Chem. 13 2013 (296-06)
211. R. Singh, and N.K. Kaushik Synthesis, spectral, thermal and anti-fungal studies of organotin (IV) thiohydrazone complexes Spectrochim. Acta A Mol. Biomol. Spectrosc. 72 2009 691 696
212. S. Shreaz, R.A. Sheikh, R. Bhatia, K. Neelofar, S.A. Imran, A. Hashmi, N. Manzoor, S.F. Basir, and L.A. Khan Antifungal activity of α-methyl trans cinnamaldehyde, its ligand and metal complexes: promising growth and ergosterol inhibitors Biometals 24 2011 923 933
213. Z.H. Chohan, H. Pervez, A. Rauf, K.M. Khan, and C.T. Supuran Isatins-derived antibacterial and antifungal compounds and their transition metal complexes J. Enzyme Inhib. Med. Chem. 19 2004 417 423
214. I. Ali, W.A. Wani, A. Khan, A. Haque, A. Ahmad, K. Saleem, and N. Manzoor Synthesis and synergistic antifungal activities of a pyrazoline based ligand and its copper(II) and nickel(II) complexes with conventional antifungals Microb. Pathog. 53 2012 66 73
215. A. Ahmad, A. Khan, L.A. Khan, and N. Manzoor In vitro synergy of eugenol and methyl eugenol with fluconazole against clinical Candida isolates J. Med. Microbiol. 59 2010 1178 1184
216. H. Quan, Y.Y. Cao, Z. Xu, J.X. Zhao, P.H. Gao, X.F. Qin, and Y.Y. Jiang Potent in vitro synergism of fluconazole and berberine chloride against clinical isolates of Candida albicans resistant to fluconazole Antimicrob. Agents Chemother. 50 2006 1096 1099
217. S. Huang, Y.Y. Cao, B.D. Dai, X.R. Sun, Z.Y. Zhu, Y.B. Cao, Y. Wang, P.H. Gao, and Y.Y. Jiang In vitro synergism of fluconazole and baicalein against clinical isolates of Candida albicans resistant to fluconazole Biol. Pharm. Bull. 31 2008 2234 2236
218. M. An, H. Shen, Y. Cao, J. Zhang, Y. Cai, R. Wang, and Y. Jiang Allicin enhances the oxidative damage effect of amphotericin B against Candida albicans Int. J. Antimicrob. Agents 33 2009 258 263
219. M. Sharma, R. Manoharlal, A.S. Negi, and R. Prasad Synergistic anticandidal activity of pure polyphenol curcumin I in combination with azoles and polyenes generates reactive oxygen species leading to apoptosis FEMS Yeast Res. 10 2010 570 578
220. N. Guo, G. Ling, X. Liang, J. Jin, J. Fan, J. Qiu, Y. Song, N. Huang, X. Wu, X. Wang, X. Deng, X. Deng, and L. Yu In vitro synergy of pseudolaric acid B and fluconazole against clinical isolates of Candida albicans Mycoses 54 2011 400 406
221. T.C. Chou Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies Pharmacol. Rev. 68 2006 621 681
222. M.V. Martin The use of fluconazole and itraconazole in the treatment of Candida albicans infections: a review J. Antimicrob. Chemother. 44 1999 429 437
223. D.W. Denning, G.G. Baily, and S.V. Hood Azole resistance in Candida Eur. J. Clin. Microbiol. 16 1997 261 280
224. M.A. Pfaller, D.J. Diekema, R.N. Jones, S.A. Messer, and R.J. Hollis SENTRY participants group, trends in antifungal susceptibility of Candida spp. isolated from pediatric and adult patients with bloodstream infections: SENTRY Antimicrobial Surveillance Program, 1997 to 2000 J. Clin. Microbiol. 40 2002 852 856
225. L. Sun, S. Sun, A. Cheng, X. Wu, Y. Zhang, and H. Lou In vitro activities of retigeric acid B alone and in combination with azole antifungal agents against Candida albicans Antimicrob. Agents Chemother. 53 2009 1586 1591
226. W. Chang, Y. Li, L. Zhang, A. Cheng, Y. Liu, and H. Lou Retigeric acid B enhances the efficacy of azoles combating the virulence and biofilm formation of Candida albicans Biol. Pharm. Bull. 35 2012 (1794-01)
227. X.L. Guo, P. Leng, Y. Yang, L.G. Yu, and H.X. Lou Plagiochin E, a botanicderived phenolic compound, reverses fungal resistance to fluconazole relating to the efflux pump J. Appl. Microbiol. 104 2008 831 838
228. R. Giordani, P. Regli, J. Kaloustian, and H. Portugal Potentiation of antifungal activity of amphotericin B by essential oil from Cinnamomum cassia Phytother. Res. 20 2006 58 61
229. F.L. Hsu, H.T. Chang, and S.T. Chang Evaluation of antifungal properties of octyl gallate and its synergy with cinnamaldehyde Bioresour. Technol. 98 2007 734 738
230. T.B. Yen, and S.T. Chang Synergistic effects of cinnamaldehyde in combination with eugenol against wood decay fungi Bioresour. Technol. 99 2008 232 236
231. M.S. Khan, and I. Ahmad Antifungal activity of essential oils and their synergy with fluconazole against drug-resistant strains of Aspergillus fumigatus and Trichophyton rubrum Appl. Microbiol. Biotechnol. 90 2011 1083 1094
232. M.S. Khan, A. Malik, and I. Ahmad Anti-candidal activity of essential oils alone and in combination with amphotericin B or fluconazole against multi-drug resistant isolates of Candida albicans Med. Mycol. 50 2012 33 42
233. M.S. Khan, and I. Ahmad Antibiofilm activity of certain phytocompounds and their synergy with fluconazole against Candida albicans biofilms J. Antimicrob. Chemother. 67 2012 618 621
234. J.H. Kim, N.C. Faria, M.L. Martins, K.L. Chan, and B.C. Campbell Enhancement of antimycotic activity of amphotericin B by targeting the oxidative stress response of Candida and cryptococcus with natural dihydroxybenzaldehydes Front. Microbiol. 3 2012 261
235. J. Stofberg, and F. Grundschober The consumption ratio and food predominance of flavoring materials Perfum Flavorist 12 1987 (27-6)
236. G.S. Clark Cinnamic aldehyde Perfum Flavorist 16 1991 (25-0)
237. D. Bickers, P. Calow, H. Greim, J.M. Hanifin, A.E. Rogers, J.H. Saurat, I.G. Sipes, R.L. Smith, H. Tagami, and RIFM expert panel. A toxicologic and dermatologic assessment of cinnamyl alcohol, cinnamaldehyde and cinnamic acid when used as fragrance ingredients Food Chem. Toxicol. 43 2005 799 836
238. S.J.T. Gowder Safety assessment of food flavor-cinnamaldehyde Biosafety 3 2014 e147
239. D.L.J. Opdyke Monographs on fragrance raw materials Food Cosmet. Toxicol. 17 1979 687 689
240. A.N. Zaitsev, and N.L. Rakhmanina Some data on the toxic properties of derivatives of phenylethyl and cinnamic alcohol Vopr. Pitan. 5 1974 (48-3)
241. A. Sporn, I. Dinu, and V. Stanciu Cercetarea toxicitatii aldehidei cinamice Igiena 14 1965 339
242. M.V. Shelanski Report to RIFM Vol. 3 2014 1
243. T.E. Drake, and H.I. Maibach Allergic contact dermatitis and stomatitis caused by a cinnamic aldehyde-flavored toothpaste Arch. Dermatol. 112 1976 202 203
244. E.A. Georgakopoulou Cinnamon contact stomatitis J. Dermatol. Case Rep. 4 2010 28 29
245. H. Endo, and T.D. Rees Clinical features of cinnamon-induced contact stomatitis Compend. Contin. Educ. Dent. 27 2006 403 409
246. V. Kirton, and D.S. Wilkinson Contact sensitivity to toothpaste Br. Med. J. 2 1973 115 116
247. B. Magnusson, and D.S. Wilkinson Cinnamic aldehyde in toothpaste. Clinical aspects and patch tests Contact Dermatitis 1 1975 70 76
248. L.G. Millard Contact sensitivity to toothpaste Br. Med. J. 1 1973 76
249. W.F. Schorr Allergic skin disease caused by cosmetics Am. Fam. Physician 12 1975 90 95
250. P.J. Bousquet, B. Guillot, J.J. Guilhou, and N. Raison-Peyron A stomatitis due to artificial cinnamon-flavored chewing gum Arch. Dermatol. 141 2005 1466 1467
251. S. Tremblay, and S.L. Avon Contact allergy to cinnamon: case report J. Can. Dent. Assoc. 74 2008 445 461
252. C.M. Allen, and G.G. Blozis Oral mucosal reactions to cinnamon-flavored chewing gum J. Am. Dent. Assoc. 116 1988 664 667
253. M. Isaac-Renton, M.K. Li, and L.M. Parsons Cinnamon spice and everything not nice: many features of intraoral allergy to cinnamic aldehyde Dermatitis 26 2015 116 121
254. FEMA (Flavor and Extract Manufacturers Association of the USA) Survey of flavoring ingredients usage levels no. 2286 Food Technology Champaign 19 1965 155
255. JECFA (FAO-WHO Joint Expert Committee on Food Additives) Specifications for the Identity and Purity of Food Addictives and their Toxicological Evaluation: Some Flavoring Substances and Non-Nutritive Sweetening Agents 1967 WHO Geneva
256. WHO (World Health Organization) Evaluation of certain food additives Tech. Rep. Ser. 710 1984 1 44
257. S.J. Gowder, and H. Devaraj Food flavor cinnamaldehyde- induced biochemical and histological changes in the kidney of male albino wistar rat Environ. Toxicol. Pharmacol. 26 2008 68 74
258. S.J. Gowder, and H. Devaraj Effect of food flavor cinnamaldehyde on the antioxidant status of rat kidney Basic Clin. Pharmacol. Toxicol. 99 2006 379 382
259. S.J. Gowder, and H. Devaraj Food flavor cinnamaldehyde induced certain behavioral and biochemical parameters of male albino wistar rat J. Med. Sci. 3 2010 101 109
260. S. Gowder, and H. Devaraj A review on the nephrotoxicity of food flavor cinnamaldehyde Curr. Bioact. Compd. 6 2010 106 117
261. S.J. Gowder Food additives - risk factors for renal failure J. Social. 3 2013 1 2
262. Council of Europe Natural Flavouring Substances, their Sources, and Added Artificial Flavouring Substances Vol. 102 1974 Council of Europe Strasbourg 145
263. RIFM (Research Institute for Fragrance Materials, Inc.) Acute Dermal Toxicity Studies in Rabbits. RIFM Report Number 2032, February 2 and 16 1973 RIFM Woodcliff Lake, NJ, USA
264. RIFM (Research Institute for Fragrance Materials, Inc.) Acute Dermal Toxicity Test of Cinnamaldehyde in Rabbits. Unpublished Report from Fritzsche Dodge and Olcott, 14 August. Report Number 8883 1986 RIFM Woodcliff Lake, NJ, USA
265. P.M. Jenner, E.C. Hagan, J.M. Taylor, E.L. Cook, and O.G. Fitzhugh Food flavorings and compounds of related structure. I. Acute oral toxicity Food Cosmet. Toxicol. 2 1964 327 343
266. National Toxicology Program Toxicology and carcinogenesis studies of trans-cinnamaldehyde (microencapsulated) in F344/N Rats and B6C3F1 mice NTP TR 514, NIH Publication No. 04-4448 2004
267. RIFM (Research Institute for Fragrance Materials, Inc.) Repeated Insult Patch Test of Cinnamaldehyde. RIFM Report Number 47158, November 22a 2004 RIFM Woodcliff Lake, NJ, USA
268. RIFM (Research Institute for Fragrance Materials, Inc.) Topical Photoallergy Screening Test of Cinnamaldehyde and Cinnamic Acid in Male Albino Hairless Guinea Pigs (Crl: IAF(HA)-hrBR (Outbred)], Including Primary Irritation, Phototoxicity and Contact Hypersensitivity Evaluations. RIFM Report Number 41273, January 15 2003 RIFM Woodcliff Lake, NJ, USA
269. A.M. Lourenco, L.M. Ferreira, and P.S. Branco Molecules of natural origin, semi-synthesis and synthesis with anti-inflammatory and anticancer utilities Curr. Pharm. Des. 18 2012 (3979-46)
270. I. Ali, S.K. Rahis-ud-din, M.A. Rather, W.A. Wani, and A. Haque Advances in nanodrugs in cancer chemotherapy Curr. Cancer Drug Targets 11 2011 135 146
271. F. Gago Molecular simulations of drug receptor complexes in anticancer research Future Med. Chem. 4 2012 1961 1970
272. A. Urruticoechea, R. Alemany, J. Balart, A. Villanueva, F. Vinals, and G. Capella Recent advances in cancer therapy: an overview Curr. Pharm. Des. 16 2010 3 10
273. N.M. Boyle, and M.J. Meegan Designed multiple ligands for cancer therapy Curr. Med. Chem. 18 2011 4722 4737